---
figid: PMC5652078__CCDT-17-637_F1
figtitle: Cyclin D–CDK4/6–INK4–Rb pathway and cell cycle control
organisms:
- Diaporthe sclerotioides
- Piromyces finnis
- Homo sapiens
- Mus musculus
pmcid: PMC5652078
filename: CCDT-17-637_F1.jpg
figlink: /pmc/articles/PMC5652078/figure/F1/
number: F1
caption: The cyclin D–CDK4/6–INK4–Rb pathway and cell cycle control. CDK, cyclin-dependent
  kinase; E2F, E2 transcription factor; ER, estrogen receptor; G, growth phase; INK4,
  inhibitor of CDK4; M, mitosis; P, phosphorylation; Rb, retinoblastoma; S, synthesis
  phase.
papertitle: 'HR+, HER2– Advanced Breast Cancer and CDK4/6 Inhibitors: Mode of Action,
  Clinical Activity, and Safety Profiles.'
reftext: Sarah L. Sammons, et al. Curr Cancer Drug Targets. 2017 Sep;17(7):637-649.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.857446
figid_alias: PMC5652078__F1
figtype: Figure
organisms_ner:
- Homo sapiens
- Mus musculus
redirect_from: /figures/PMC5652078__F1
ndex: b71ad06f-dea1-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5652078__CCDT-17-637_F1.html
  '@type': Dataset
  description: The cyclin D–CDK4/6–INK4–Rb pathway and cell cycle control. CDK, cyclin-dependent
    kinase; E2F, E2 transcription factor; ER, estrogen receptor; G, growth phase;
    INK4, inhibitor of CDK4; M, mitosis; P, phosphorylation; Rb, retinoblastoma; S,
    synthesis phase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CDK4
  - CDK6
  - CCND1
  - CCND2
  - CCND3
  - E2F1
  - E2F2
  - E2F3
  - E2F4
  - E2F5
  - E2F6
  - E2F7
  - E2F8
  - WARS1
  - Cdk4
  - Cdk6
  - Gabrg2
  - Estrogen
---
